Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression.
Lucas VuKrystine Garcia-MansfieldAntonio PompeianoJiyan AnVictoria David-DirgoRitin SharmaVinisha VenugopalHarkeerat HalaitGuido MarcucciYa-Huei KuoLisa UechiRussell C RocknePatrick PirrotteRobert BowserPublished in: Annals of clinical and translational neurology (2023)
We identified pathways and protein biomarkers that distinguish rate of ALS disease progression. A mathematical model of the CSF proteome determined that the change in entropy of the proteome over time was predictive of FP versus SP.